First Quadrant’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Quadrant’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,000	Closed	-$351K	–	720
2020 Q1	$351K	Hold	1,000	–	–	0.05%	323
2019 Q4	$370K	Hold	1,000	–	–	0.03%	339
2019 Q3	$333K	Hold	1,000	–	–	0.03%	358
2019 Q2	$313K	Hold	1,000	–	–	0.02%	463
2019 Q1	$306K	Hold	1,000	–	–	0.02%	432
2018 Q4	$232K	Sell	1,000 -8,503	-89%	-$2.28M	0.02%	504
2018 Q3	$2.97M	Hold	9,503	–	–	0.07%	260
2018 Q2	$2.74M	Sell	9,503 -8,176	-46%	-$2.26M	0.05%	290
2018 Q1	$4.42M	Buy	17,679 +16,679	+1,668%	+$4.25M	0.08%	240
2017 Q4	$239K	Sell	1,000 -12,740	-93%	-$3.09M	﹤0.01%	687
2017 Q3	$3.05M	Hold	13,740	–	–	0.06%	298
2017 Q2	$3.11M	Sell	13,740 -31,019	-69%	-$6.76M	0.06%	281
2017 Q1	$8.92M	Sell	44,759 -11,703	-21%	-$2.25M	0.18%	189
2016 Q4	$10.3M	Buy	56,462 +24,462	+76%	+$4.17M	0.21%	161
2016 Q3	$5.24M	Hold	32,000	–	–	0.11%	226
2016 Q2	$4.58M	Sell	32,000 -26,900	-46%	-$3.84M	0.1%	208
2016 Q1	$8.05M	Buy	58,900 +31,300	+113%	+$4.11M	0.18%	169
2015 Q4	$3.83M	Hold	27,600	–	–	0.08%	238
2015 Q3	$3.71M	Buy	27,600 +15,600	+130%	+$2.25M	0.08%	237
2015 Q2	$1.81M	Buy	+12,000	New	+$1.72M	0.04%	291

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

First Quadrant's BIO Position: Q2 2020 in Review

First Quadrant sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 1,000 shares — an estimated $351K sold.

First Quadrant first reported a position in BIO in Q2 2015 and held it in 20 quarters. The position peaked at $10.3M in Q4 2016. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

First Quadrant reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
First Quadrant sold 1,000 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $351K.
First Quadrant first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and held it in 20 quarters.
First Quadrant's Bio-Rad Laboratories Class A position peaked at $10.3M in Q4 2016.
470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on First Quadrant's 13F filing for Q2 2020, filed 28 Jul 2020.